A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge ; volume:8 ; number:1 ; day:16 ; month:7 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (16.7.2018), 1-11, 12.2018

Creator: Lin, Yu-Li

Contributor: Chow, Yen-Hung
Huang, Li-Min
Hsieh, Szu-Min
Cheng, Pei-Yun
Hu, Kai-Chieh
Chiang, Bor-Luen
SpringerLink (Online service)

DOI: 10.1038/s41598-018-28281-5

URN: urn:nbn:de:101:1-2018091821091547645502

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lin, Yu-Li
Chow, Yen-Hung
Huang, Li-Min
Hsieh, Szu-Min
Cheng, Pei-Yun
Hu, Kai-Chieh
Chiang, Bor-Luen
SpringerLink (Online service)

Other Objects (12)

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge

Adjuvanted infuenza vaccine dynamics

Adjuvanted influenza vaccine dynamics

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice

Related objects

Reset password